Achievement of sufficient antibody response after a fourth dose of wild-type SARS-CoV-2 mRNA vaccine in nursing home residents.

Yong ChongTakeyuki GotoHaruka WatanabeNaoki TaniAkiko YonekawaHideyuki IkematsuNobuyuki ShimonoYosuke TanakaKoichi Akashi

Published in: Immunity, inflammation and disease (2023)

Advanced aged nursing home residents, poor responders in the initial SARS-CoV-2 vaccine series, could achieve sufficient antibody responses after the fourth (second booster) vaccination, comparable to those of younger adults.

Keyphrases

sars cov
wild type
respiratory syndrome coronavirus
binding protein
coronavirus disease